8-K
filed May 25, 2023, 7:59 PM ET
ticker MDT
CIK 0001613103
earnings
confidence high
sentiment positive
materiality 0.85
Medtronic Q4 revenue beats at $8.5B (+5.6%); raises dividend to $0.69 quarterly
Medtronic plc
2023-FY EPS reported
$2.82
revenue$31,227,000,000
- Q4 GAAP EPS $0.88 (-20% YoY); non-GAAP EPS $1.57 (+3%), ahead of expectations.
- FY23 revenue $31.2B (-1.4% reported, +2.1% organic); FY organic growth guided 4.0-4.5%.
- Dividend increased to $0.69/share quarterly ($2.76 annual); 46th consecutive annual increase.
- Announced definitive agreement to acquire EOFlow Co. Ltd. (EOPatch tubeless insulin pump).
- FY24 non-GAAP EPS guidance $5.00-$5.10; revenue positively impacted by FX ~$110-210M.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Medtronic plc reported fiscal year 2023 results: revenue $31.227 billion, net income $3.758 billion, EPS $2.82.
- Period
- fiscal year 2023
- Revenue
- $31.227 billion
- Net income
- $3.758 billion
- EPS
- $2.82
- Result
- reported results
Exact text from the filing
non-GAAP diluted EPS were $2.093 billion and $1.57, respectively, both increases of 3%. Fiscal Year 2023 (FY23) Financial Results Medtronic reported FY23 worldwide revenue of $31.227 billion, a decrease of 1.4% as reported and an increase of 2.1% on an organic basis. The FY23 organic revenue growth comparison excludes: • a $1.437 billion negative impact from foreign
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Medtronic plc reported fourth quarter fiscal year 2023 results: revenue $8.5 billion, net income $1.179 billion, EPS $0.88.
- Period
- fourth quarter fiscal year 2023
- Revenue
- $8.5 billion
- Net income
- $1.179 billion
- EPS
- $0.88
- Result
- reported results
Exact text from the filing
Q4 revenue of $8.5 billion increased 5.6% as reported and organic, ahead of expectations • Q4 GAAP diluted EPS of $0.88 decreased 20%; non-GAAP diluted EPS of $1.57 increased 3% in the quarter, ahead of expectations
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.